CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
Clinical trial NCT00327418 · COMPLETED
Trial details
- NCT number
- NCT00327418
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 1997-01-01
- Enrollment
- 2800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.